Form4insider filings, from the source

SEC Form 4 · accession 0001493152-26-037489

Hepion Pharmaceuticals, Inc. · HEPA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Vincent S LoPriore
Officer — Executive Chairman · Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 12, 2026 · 9:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583771

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 3, 2026P8,000,000$0.05A14,250,000IBy Gravitas Capital LP
Common StockF2Aug 3, 2026P2,000,000$0.05A16,250,000IBy Invictus Capital Advisors Pension Plan

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF1$0.06Aug 3, 2026P8,000,000AAug 3, 2026Aug 3, 2031Common Stock8,000,0008,000,000I
WarrantsF2$0.06Aug 3, 2026P2,000,000AAug 3, 2026Aug 3, 2031Common Stock2,000,00010,000,000I

Explanation of responses